KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Incyte (INCY) Operating Expenses: 2009-2024

Historic Operating Expenses for Incyte (INCY) over the last 16 years, with Dec 2024 value amounting to $4.2 billion.

  • Incyte's Operating Expenses fell 6.99% to $922.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.3 billion, marking a year-over-year decrease of 19.28%. This contributed to the annual value of $4.2 billion for FY2024, which is 35.92% up from last year.
  • Incyte's Operating Expenses amounted to $4.2 billion in FY2024, which was up 35.92% from $3.1 billion recorded in FY2023.
  • Incyte's 5-year Operating Expenses high stood at $4.2 billion for FY2024, and its period low was $2.4 billion during FY2021.
  • For the 3-year period, Incyte's Operating Expenses averaged around $3.4 billion, with its median value being $3.1 billion (2023).
  • As far as peak fluctuations go, Incyte's Operating Expenses soared by 66.81% in 2020, and later fell by 18.08% in 2021.
  • Over the past 5 years, Incyte's Operating Expenses (Yearly) stood at $2.9 billion in 2020, then dropped by 18.08% to $2.4 billion in 2021, then grew by 17.28% to $2.8 billion in 2022, then rose by 9.23% to $3.1 billion in 2023, then skyrocketed by 35.92% to $4.2 billion in 2024.